PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-123.79%
Both yoy net incomes decline, with VET at -87.77%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
8.33%
D&A growth well above VET's 1.49%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-143.36%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
135.11%
SBC growth well above VET's 34.54%. Michael Burry would flag major dilution risk vs. competitor’s approach.
156.52%
Slight usage while VET is negative at -25.52%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
8600.00%
AR growth of 8600.00% while VET is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
156.52%
Some yoy usage while VET is negative at -25.52%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
65.97%
Well above VET's 98.79%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-5.37%
Negative yoy CFO while VET is 13.88%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-110.89%
Both yoy lines negative, with VET at -64.88%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-81.68%
Both yoy lines negative, with VET at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
142.19%
We have some outflow growth while VET is negative at -106.23%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-732.88%
Both yoy lines negative, with VET at -157.14%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
9.09%
We repay more while VET is negative at -24.27%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.